[Pathogenesis of glucocorticoid-induced osteoporosis based on label-free mass proteomics]

Zhongguo Gu Shang. 2023 Apr 25;36(4):336-44. doi: 10.12200/j.issn.1003-0034.2023.04.008.
[Article in Chinese]

Abstract

Objective: To explore pathogenesis of glucocortocoid-induced osteoporosis(GIOP) based on label-free mass proteomics.

Methods: Twevle female Sprague-Dawley(SD) rats were randomly divided into two groups, named as sham group and GIOP group. After one-week adaptive feeding, the rats of GIOP group were administered with dexamethasone via intramuscular injection according to 2.5 mg/kg weighting, while the rats of sham group were administered with the same amount of saline, twice a week. The tibias of each group were collected after 8-week modeling and made pathological sections to confirm the success of modeling. Three samples of each group were picked up to perform label-free mass proteomics. After quality control, differentially expressed proteins were identified according to qualitative and quantitative analyses. Then gene ontology(GO) and Kyoto encyclopedia of genes and genomes (KEGG) enrichment analysis, cluster analysis as well as protein-protein interaction analysis were performed using bioinformatics analysis.

Results: Compared with sham group, the structure of bone trabecular in GIOP group showed abnormal arrangement, uneven distribution and obvious fragmentation, which could demonstrate successful modeling. A total of 47 differentially expressed proteins (DEPs) were identified including 20 up-regulated and 27 down-regulated proteins. The expression of protein nucleophosmin 1(NPM1), adipocyte plasma membrane associated protein (APMAP), cytochromec oxidase subunit 6A1 (COX6A1) and tartrate-resistant acid phosphatase (ACP5) showed a significant difference between two groups. KEGG results showed DEPs were enriched on metabolism-related pathways, immune-related pathways and AMP-activated kinase (AMPK) signaling pathway.

Conclusion: Protein NPM1, APMAP, COX6A1 and ACP5 showed a close relationship with pathogenesis of GIOP, which could serve as potential biomarkers of GIOP. AMPK signaling pathway played an important role in the occurrence and development of GIOP, which could be regarded as potential signaling pathway to treatment GIOP.

Keywords: Glucocorticoid-induced osteoporosis; Pathogenesis; Proteomics.

Publication types

  • English Abstract

MeSH terms

  • AMP-Activated Protein Kinases
  • Animals
  • Female
  • Glucocorticoids* / adverse effects
  • Nuclear Proteins / adverse effects
  • Osteoporosis* / chemically induced
  • Osteoporosis* / genetics
  • Proteomics
  • Rats
  • Rats, Sprague-Dawley

Substances

  • Glucocorticoids
  • AMP-Activated Protein Kinases
  • Nuclear Proteins